Robotic surgery breakthrough aims to slash lung cancer recovery time
NCT ID NCT05832112
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new robotic surgery technique for stage I lung cancer. Instead of making cuts between the ribs, surgeons place the robot's tools below the ribcage. The goal is to see if this approach is safe and feasible, and if it can reduce pain and hospital stays. The trial will enroll 20 patients at a single hospital in Canada.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
robotic surgery procedure (OTC RATS lobectomy)
What this could lead to
If successful, this technique could offer a less painful, faster-recovering surgical option for early-stage lung cancer patients.
What could go wrong
This is a very early, small pilot study (20 patients) testing feasibility and safety. The new approach may not work as hoped or could have unexpected complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER STAGE I are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHUM
Montreal, Quebec, H2X 0A9, Canada